Oncopharmpod
Jan 2024 Updates...
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:15:25
- Mas informaciones
Informações:
Sinopsis
...on FDA approvals for belzutifan for RCC, pembrolizumab + cisplatin/RT for cervical cancer, erdafitinib (FGFR3 alterations only) for bladder cancer. Plus, early morning ICIs (https://doi.org/10.1016/j.ejca.2024.113571) & FLAG-Ida-GO in AML from NCRI AML 19 (https://doi.org/10.1200/JCO.23.00943)
